177 related articles for article (PubMed ID: 38511244)
1. Utilization of broad- versus narrow-spectrum antibiotics for the treatment of outpatient community-acquired pneumonia among adults in the United States.
Nickel KB; Durkin MJ; Olsen MA; Sahrmann JM; Neuner E; O'Neil CA; Butler AM;
Pharmacoepidemiol Drug Saf; 2024 Apr; 33(4):e5779. PubMed ID: 38511244
[TBL] [Abstract][Full Text] [Related]
2. Multistep antimicrobial stewardship intervention on antibiotic prescriptions and treatment duration in children with pneumonia.
Rossin S; Barbieri E; Cantarutti A; Martinolli F; Giaquinto C; Da Dalt L; Doná D
PLoS One; 2021; 16(10):e0257993. PubMed ID: 34705849
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Empiric Antibiotic Treatment Regimens for Hospitalized, Non-severe Community-acquired Pneumonia: A Retrospective, Multicenter Cohort Study.
Reeves SD; Hartmann AP; Tedder AC; Juang PA; Hofer M; Kollef MH; Micek ST; Betthauser KD
Clin Ther; 2024 Apr; 46(4):338-344. PubMed ID: 38403509
[TBL] [Abstract][Full Text] [Related]
4. Effect of β-Lactam Plus Macrolide Versus Fluoroquinolone on 30-Day Readmissions for Community-Acquired Pneumonia.
Gilbert TT; Arfstrom RJ; Mihalovic SW; Dababneh AS; Varatharaj Palraj BR; Dierkhising RA; Mara KC; Lessard SR
Am J Ther; 2020; 27(2):e177-e182. PubMed ID: 30418221
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis and management of community-acquired pneumonia in adults.
Watkins RR; Lemonovich TL
Am Fam Physician; 2011 Jun; 83(11):1299-306. PubMed ID: 21661712
[TBL] [Abstract][Full Text] [Related]
6. Variability in Antibiotic Prescribing for Community-Acquired Pneumonia.
Handy LK; Bryan M; Gerber JS; Zaoutis T; Feemster KA
Pediatrics; 2017 Apr; 139(4):. PubMed ID: 28270546
[TBL] [Abstract][Full Text] [Related]
7. Antibiotic Choice and Clinical Outcomes in Ambulatory Children with Community-Acquired Pneumonia.
Lipsett SC; Hall M; Ambroggio L; Hersh AL; Shah SS; Brogan TV; Gerber JS; Williams DJ; Grijalva CG; Blaschke AJ; Neuman MI
J Pediatr; 2021 Feb; 229():207-215.e1. PubMed ID: 33045236
[TBL] [Abstract][Full Text] [Related]
8. Comparative effectiveness of empiric antibiotics for community-acquired pneumonia.
Queen MA; Myers AL; Hall M; Shah SS; Williams DJ; Auger KA; Jerardi KE; Statile AM; Tieder JS
Pediatrics; 2014 Jan; 133(1):e23-9. PubMed ID: 24324001
[TBL] [Abstract][Full Text] [Related]
9. The etiology of community-acquired pneumonia in Australia: why penicillin plus doxycycline or a macrolide is the most appropriate therapy.
Charles PG; Whitby M; Fuller AJ; Stirling R; Wright AA; Korman TM; Holmes PW; Christiansen KJ; Waterer GW; Pierce RJ; Mayall BC; Armstrong JG; Catton MG; Nimmo GR; Johnson B; Hooy M; Grayson ML;
Clin Infect Dis; 2008 May; 46(10):1513-21. PubMed ID: 18419484
[TBL] [Abstract][Full Text] [Related]
10. How good is the evidence for the recommended empirical antimicrobial treatment of patients hospitalized because of community-acquired pneumonia? A systematic review.
Oosterheert JJ; Bonten MJ; Hak E; Schneider MM; Hoepelman IM
J Antimicrob Chemother; 2003 Oct; 52(4):555-63. PubMed ID: 12972448
[TBL] [Abstract][Full Text] [Related]
11. Broad- versus Narrow-Spectrum Oral Antibiotic Transition and Outcomes in Health Care-associated Pneumonia.
Buckel WR; Stenehjem E; Sorensen J; Dean N; Webb B
Ann Am Thorac Soc; 2017 Feb; 14(2):200-205. PubMed ID: 27690519
[TBL] [Abstract][Full Text] [Related]
12. Comparative Treatment Failure Rates of Respiratory Fluoroquinolones or β-Lactam + Macrolide Versus β-Lactam Alone in the Treatment for Community-Acquired Pneumonia in Adult Outpatients: An Analysis of a Nationally Representative Claims Database.
Lee MG; Lee SH; Chang SS; Chan YL; Pang L; Hsu SM; Lee CC
Medicine (Baltimore); 2015 Sep; 94(39):e1662. PubMed ID: 26426664
[TBL] [Abstract][Full Text] [Related]
13. Medical resource utilization among community-acquired pneumonia patients initially treated with levofloxacin 750 mg daily versus ceftriaxone 1000 mg plus azithromycin 500 mg daily: a US-based study.
Frei CR; Jaso TC; Mortensen EM; Restrepo MI; Raut MK; Oramasionwu CU; Ruiz AD; Makos BR; Ruiz JL; Attridge RT; Mody SH; Fisher A; Schein JR
Curr Med Res Opin; 2009 Apr; 25(4):859-68. PubMed ID: 19231913
[TBL] [Abstract][Full Text] [Related]
14. Treatment failure rates and health care utilization and costs among patients with community-acquired pneumonia treated with levofloxacin or macrolides in an outpatient setting: a retrospective claims database analysis.
Ye X; Sikirica V; Schein JR; Grant R; Zarotsky V; Doshi D; Benson CJ; Riedel AA
Clin Ther; 2008 Feb; 30(2):358-71. PubMed ID: 18343274
[TBL] [Abstract][Full Text] [Related]
15. Community-Acquired Pneumonia in Adults: Diagnosis and Management.
Kaysin A; Viera AJ
Am Fam Physician; 2016 Nov; 94(9):698-706. PubMed ID: 27929242
[TBL] [Abstract][Full Text] [Related]
16. Antibiotic treatment patterns, costs, and resource utilization among patients with community acquired pneumonia: a US cohort study.
Llop CJ; Tuttle E; Tillotson GS; LaPlante K; File TM
Hosp Pract (1995); 2017 Feb; 45(1):1-8. PubMed ID: 28064542
[TBL] [Abstract][Full Text] [Related]
17. Adherence to infectious diseases society of America guidelines for empiric therapy for patients with community-acquired pneumonia in a commercially insured cohort.
Wu JH; Howard DH; McGowan JE; Turpin RS; Henry Hu X
Clin Ther; 2006 Sep; 28(9):1451-61. PubMed ID: 17062317
[TBL] [Abstract][Full Text] [Related]
18. Atypical coverage in community-acquired pneumonia after outpatient beta-lactam monotherapy.
van Werkhoven CH; van de Garde EMW; Oosterheert JJ; Postma DF; Bonten MJM
Respir Med; 2017 Aug; 129():145-151. PubMed ID: 28732822
[TBL] [Abstract][Full Text] [Related]
19. Comparative Efficacy of Beta-Lactams and Macrolides in the Treatment of Pediatric Pneumonia: A Systematic Review.
Al Saeedy D; Gillani SW; Al-Salloum J; Moosvi A; Eissa M; Gulam SM
Curr Pediatr Rev; 2020; 16(4):307-313. PubMed ID: 32895041
[TBL] [Abstract][Full Text] [Related]
20. Outpatient Antimicrobial Stewardship: Targets for Community-acquired Pneumonia.
Wattengel BA; Sellick JA; Skelly MK; Napierala R; Schroeck J; Mergenhagen KA
Clin Ther; 2019 Mar; 41(3):466-476. PubMed ID: 30739721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
